MIF and autoimmune disease: Accordingly, inhibition of MIF has been proposed as a potentially effective therapeutic strategy for the treatment of inflammatory and autoimmune diseases, in particular in conditions associated with glucocorticoid resistance or glucocorticoid dependence (11).